Home > News > Latest > Are pharma industry companies converting patients with orphan diseases into lobbyists?

Are pharma industry companies converting patients with orphan diseases into lobbyists?

Wearing a blue T-shirt and worn jeans, Marc Yale stood near the welcome pole at the annual Rare Disease Legislative Advocates conference handing out money.

Spotlight

Other News

Dom Nicastro | April 03, 2020

More Trending news

Spotlight

Resources

How long will the world wait for the next pandemic of antimicrobial resistance before we act?

Article

Driving Down Drug Costs: How Real-Time Transparency in PBMs Can Make a Difference

Article

The Globalization Of The Pharmaceutical Industry

Whitepaper

How long will the world wait for the next pandemic of antimicrobial resistance before we act?

Article

Driving Down Drug Costs: How Real-Time Transparency in PBMs Can Make a Difference

Article

The Globalization Of The Pharmaceutical Industry

Whitepaper